Brellium Raises $23 Million to Expand AI Compliance

The AI-powered clinical compliance platform unveiled CortexLM, a system for finding care and documentation gaps in patient notes.

Updated on Nov. 20, 2026 in Startups

Empty ergonomic chairs at a bare oak table beside a tall window overlooking a grey city block, with a stack of blank folders at one end.
Brellium, a New York-based health-tech company, raised $23 million led by Left Lane Capital and First Round Capital to expand its AI compliance platform for clinical notes. AI Illustration. Upload story photo >

Live Poll

Would you trust AI software to review your medical records for billing errors?

Brellium has raised $23 million in venture funding led by Left Lane Capital and First Round Capital, with Digital Health Venture Partners also participating. The New York City-founded company also unveiled CortexLM, which analyzes patient notes for gaps in care and compliance.

Why it matters

Brellium says its platform is used by more than 215,000 providers across all 50 states, indicating how widely clinical documentation and coding compliance tools are being adopted in the U.S. health care market. The financing will support expansion to additional provider groups and specialties.

Brellium reports $23 million in venture funding and says its platform is used by more than 215,000 providers across all 50 states, with 100% of clinical documentation and coding audited. The source does not disclose valuation, revenue, or independent verification of these operational figures.

The players

Brellium

Brellium is a New York City-founded company that offers an AI-powered clinical compliance and revenue integrity platform used by health care providers.

First Round Capital

First Round Capital is a venture capital firm that led the funding round for Brellium alongside Left Lane Capital.

Left Lane Capital

Left Lane Capital is an investment firm that co-led Brellium's $23 million venture funding round.

The details

Brellium, an AI-powered clinical compliance and revenue integrity platform, unveiled CortexLM, which analyzes patient notes for gaps in care and compliance. The company plans to use the new capital to serve more provider groups across additional specialties and to go deeper into the revenue cycle.

Timeline

  1. November 20, 2026: Brellium announced the $23 million funding and unveiled CortexLM.

Market Landscape

Brellium's CortexLM extends its existing audit platform into patient-note analysis as the company seeks to widen its reach across U.S. provider groups and deeper into the revenue cycle. The funding round signals investor interest in AI tools that target clinical documentation and billing compliance.

For health care providers, Brellium's expansion means more tools may be available to review clinical documentation and coding for compliance gaps. The source does not indicate pricing changes or how individual providers would access the platform.

The takeaway

Health care organizations evaluating AI compliance tools may want to compare how each platform audits documentation and coding before adopting one. As venture funding flows into this category, providers should watch how these products handle accuracy and oversight.

Further reading

Explore more Startups coverage to see how early-stage health-tech companies are raising capital and scaling their platforms.

Source note: This article includes information reported by Vcnewsdaily.

Live Poll

Would you trust AI software to review your medical records for billing errors?